Bantam Pharmaceutical Employee Directory

Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees

Bantam Pharmaceutical is a small oncology-focused drug discovery and development company that centers its work on mitochondrial dynamics in cancer. It develops oral, first-in-class small molecules aimed at hard-to-treat hematologic and solid tumors, led by its lead candidate BTM-3566. The company is based in Durham, North Carolina, and holds an active IND in the United States and a Clinical Trial Application in Canada for BTM-3566, with plans to broaden development to solid tumors. Its compact team focuses on advancing early-stage clinical programs.

BTM-3566 is positioned to address a wide range of cancers, with an initial clinical focus on mature B-cell lymphomas, including mantle cell lymphoma, diffuse large B-cell lymphoma, and follicular lymphoma. In preclinical studies, the compound showed robust anti-cancer activity, driving tumor regression and, in many cases, complete tumor elimination in models resistant to standard treatments such as CAR-T therapy. Its mechanism involves disrupting mitochondrial function in tumor cells to induce apoptosis. A recent development is Bantam's partnership with the University of Illinois at Chicago announced in February 2026, reflecting ongoing collaboration to advance its research agenda.

Sign up for free to view info

Company overview Email format